Insider · CIK 0001822014

Cordova Ashley

Reports to the SEC for 1 company · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001822014

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-04	NVCRNovoCure LtdF Tax Payment	Former Chief Executive Officer	FTax Payment	−17.6K sh	$13.30	−$235K	422,570
2026-03-02	NVCRNovoCure LtdF Tax Payment	Former Chief Executive Officer	FTax Payment	−2,410 sh	$13.67	−$32.9K	447,436
2026-03-02	NVCRNovoCure LtdF Tax Payment	Former Chief Executive Officer	FTax Payment	−7,228 sh	$13.67	−$98.8K	440,208
2026-02-28	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+23.8K sh	—	—	449,846
2026-02-27	NVCRNovoCure LtdF Tax Payment	Former Chief Executive Officer	FTax Payment	−11.5K sh	$13.75	−$159K	426,028
2025-09-05	NVCRNovoCure LtdP Purchase	Former Chief Executive Officer	PPurchase	+81.6K sh	$12.22	+$997K	437,569
2025-06-30	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+833 sh	$15.13	+$12.6K	356,019
2025-03-04	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+151K sh	$18.19	+$2.75M	355,186
2025-03-04	NVCRNovoCure Ltd · Stock Options (Right to buy)A Award	Former Chief Executive Officer	AAward	+224K sh	$18.19	+$4.08M	224,123
2025-03-03	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−2,053 sh	$18.54	−$38.1K	204,005
2025-02-28	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−2,341 sh	$18.28	−$42.8K	206,058
2025-02-28	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−2,341 sh	$18.28	−$42.8K	206,058
2025-02-27	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−9,345 sh	$19.92	−$186K	210,207
2025-02-27	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−1,808 sh	$20.55	−$37.2K	208,399
2025-02-27	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−9,345 sh	$19.92	−$186K	210,207
2025-02-27	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−1,808 sh	$20.55	−$37.2K	208,399
2024-12-31	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+373 sh	$14.75	+$5,501.004	219,552
2024-08-02	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−688 sh	$20.14	−$13.9K	219,179
2024-06-28	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+1,286 sh	$12.24	+$15.7K	220,465
2024-02-27	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+102K sh	$16.30	+$1.67M	219,867
2024-02-27	NVCRNovoCure Ltd · Stock Options (Right to buy)A Award	Former Chief Executive Officer	AAward	+156K sh	$16.30	+$2.55M	156,348
2023-11-02	NVCRNovoCure LtdM Exercise/Conversion	Former Chief Executive Officer	MExercise/Conversion	+175 sh	$11.46	+$2,005.5	117,618
2023-11-02	NVCRNovoCure Ltd · Stock Option (Right to Buy)M Exercise/Conversion	Former Chief Executive Officer	MExercise/Conversion	−175 sh	—	—	0
2023-10-31	NVCRNovoCure LtdM Exercise/Conversion	Former Chief Executive Officer	MExercise/Conversion	+7,561 sh	$11.46	+$86.6K	107,211
2023-10-31	NVCRNovoCure LtdM Exercise/Conversion	Former Chief Executive Officer	MExercise/Conversion	+2,480 sh	$11.44	+$28.4K	109,691
2023-10-31	NVCRNovoCure LtdM Exercise/Conversion	Former Chief Executive Officer	MExercise/Conversion	+7,752 sh	$7.15	+$55.4K	117,443
2023-10-31	NVCRNovoCure Ltd · Stock Option (Right to Buy)M Exercise/Conversion	Former Chief Executive Officer	MExercise/Conversion	−7,561 sh	—	—	175
2023-10-31	NVCRNovoCure Ltd · Stock Option (Right to Buy)M Exercise/Conversion	Former Chief Executive Officer	MExercise/Conversion	−2,480 sh	—	—	0
2023-10-31	NVCRNovoCure Ltd · Stock Option (Right to Buy)M Exercise/Conversion	Former Chief Executive Officer	MExercise/Conversion	−7,752 sh	—	—	0
2023-09-01	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−883 sh	$21.82	−$19.3K	99,650
2023-08-02	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−1,144 sh	$30.25	−$34.6K	100,533
2023-06-30	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+367 sh	$35.28	+$12.9K	101,677
2023-03-03	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+11.8K sh	—	—	106,815
2023-03-03	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−4,730 sh	$76.16	−$360K	102,085
2023-03-03	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−775 sh	$76.16	−$59K	101,310
2023-03-02	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−1,055 sh	$75.28	−$79.4K	95,007
2023-03-01	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−2,198 sh	$76.36	−$168K	96,062
2023-02-28	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+23.8K sh	—	—	98,260
2023-02-28	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Former Chief Executive Officer	AAward	+39.6K sh	$76.97	+$3.05M	39,614
2023-01-06	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+66 sh	$62.30	+$4,112.13	74,442
2022-12-02	NVCRNovoCure LtdM Exercise/Conversion	Former Chief Executive Officer	MExercise/Conversion	+2,000 sh	$7.15	+$14.3K	74,376
2022-12-02	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Former Chief Executive Officer	MExercise/Conversion	−2,000 sh	$7.15	−$14.3K	7,752
2022-09-02	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−885 sh	$79.04	−$69.9K	72,376
2022-08-02	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+7,122 sh	$70.20	+$500K	73,261
2022-07-05	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+251 sh	$59.08	+$14.8K	66,139
2022-03-08	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−759 sh	$70.10	−$53.2K	60,848
2022-03-04	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−556 sh	$70.41	−$39.1K	61,607
2022-03-03	NVCRNovoCure LtdA Award	Former Chief Executive Officer	AAward	+21.5K sh	—	—	63,312
2022-03-03	NVCRNovoCure LtdS Sale	Former Chief Executive Officer	SSale	−1,149 sh	$74.50	−$85.6K	62,163
2022-03-03	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Former Chief Executive Officer	AAward	+37.7K sh	$80.59	+$3.04M	37,664

Recent filings

Accepted (ET)
Mar 54
Cordova Ashley0001822014-26-000003
SEC(opens sec.gov)
Mar 34
Cordova Ashley0001822014-26-000002
SEC(opens sec.gov)
Sep 84
Cordova Ashley0001562180-25-006130
SEC(opens sec.gov)
Jul 14
Cordova Ashley0001562180-25-005186
SEC(opens sec.gov)
Mar 64
Cordova Ashley0001562180-25-002156
SEC(opens sec.gov)
Mar 44
Cordova Ashley0001562180-25-001975
SEC(opens sec.gov)
Mar 34
Cordova Ashley0001562180-25-001833
SEC(opens sec.gov)
Mar 34/A
Cordova Ashley0001562180-25-001916
SEC(opens sec.gov)
Jan 34
Cordova Ashley0001562180-25-000066
SEC(opens sec.gov)
Aug 64
Cordova Ashley0001562180-24-006040
SEC(opens sec.gov)
Aug 54
Cordova Ashley0001562180-24-005984
SEC(opens sec.gov)
Feb 294
Cordova Ashley0001562180-24-001989
SEC(opens sec.gov)

Companies

NovoCure LtdFormer Chief Executive OfficerNVCR

Address

C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115

WAYNE, PA, 19087